CNS Pharmaceuticals, Inc. (CNSP) vs Ensysce Biosciences, Inc. (ENSC)
CNS Pharmaceuticals, Inc. and Ensysce Biosciences, Inc. are both Biotechnology companies. CNS Pharmaceuticals, Inc. and Ensysce Biosciences, Inc. are of similar size ($7.8M and $7.5M). CNS Pharmaceuticals, Inc. has the higher net margin (0.00% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, CNS Pharmaceuticals, Inc. leads on 9 and Ensysce Biosciences, Inc. on 2.
Valuation
Profitability
| Metric | CNSP | ENSC | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (281.32%) | 0.00% |
| Net margin | 0.00% | (280.49%) | 0.00% |
| Free cash flow margin | 0.00% | (196.76%) | 0.00% |
| Return on equity | (106.62%) | (1,295.01%) | (57.72%) |
| Return on assets | (91.64%) | (295.92%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack